MetLife Investment Management’s 908 Devices MASS Stock Holding History
Bought
Maintained
Sold
Other funds holding MASS
FLAM
AIC
AIM
NIM
GIM
MetLife Investment Management's MASS Position: Q2 2026 in Review
MetLife Investment Management increased its 908 Devices (MASS) stake by 1.6% in Q2 2026, buying an estimated $2.07K and bringing the position to 17,292 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #2566.
MetLife Investment Management first reported a position in MASS in Q1 2021 and has held it in 18 quarters since. The position peaked at $247K in Q2 2022. 112 funds tracked by Wall St. Rank hold MASS as of Q2 2026.
- MetLife Investment Management held 17,292 shares of 908 Devices worth $150K as of Q2 2026.
- MetLife Investment Management bought 270 908 Devices shares in Q2 2026, an estimated $2.07K.
- 908 Devices made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2566 holding.
- MetLife Investment Management first reported a position in 908 Devices in Q1 2021 and has held it in 18 quarters since.
- MetLife Investment Management's 908 Devices position peaked at $247K in Q2 2022.
- 112 funds tracked by Wall St. Rank held 908 Devices as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.